Tanya Gottlieb

Tanya has over 20 years of experience in academia and biotech, specializing in building and cultivating international collaborations and securing non-dilutive financing. Before joining MeMed, Tanya was Director of Business Development at BiondVax Pharmaceuticals Ltd (NASDAQ: BVXV), an innovative start-up developing a universal flu vaccine, where she initiated collaborations with the National Institute of Health (US) and the European Commission. Prior to that, Tanya served as an independent consultant for key opinion leaders in Israel and Europe, helping to maximize their impact in the field and win awards. Tanya conducted her postdoctoral research at the Weizmann Institute of Science, Israel, and the Fred Hutchinson Cancer Research Center in Seattle, WA, USA. Tanya holds a B.A. in Natural Sciences and Ph.D. from Cambridge University, UK., and an MBA from the Technion, Israel. She is the co-author of over 20 peer-reviewed publications and the recipient of multiple awards, including the prestigious Royal Society (UK)-Israel Academy Fellowship.